TOWARDS DIGITAL-BASED CARE OF SCHIZOPHRENIA: WHERE ARE WE HEADING?
This symposium chaired by Dr. Taishiro Kishimoto and co-chaired by Dr. John Torous gave participants the latest highlights on devices and programs that utilize real-life data to assess better treatment and management of severe mental disorders.
COGNITIVE IMPAIRMENT AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
This symposium, chaired by Professor Gabriele Sachs and Professor István Bitter, elaborated on the significance of cognitive and negative symptoms in real-life functioning and illness-related outcomes as well as on the current treatment options for these symptoms
CARIPRAZINE AS A BROAD-SPECTRUM TREATMENT
Gedeon Richter and Recordati organised a satellite symposium that aimed at exploring the broad-spectrum treatment of schizophrenia and cariprazine’s role in addressing wide-ranging needs, as supported by both clinical data and real-life experience.
